by Peter Ciszewski | Oct 10, 2017
Robert Derham, Founder of CheckOrphan, discusses some of the misconceptions regarding drug makers’ patent exclusivity and the Orphan Drug Act.
by Peter Ciszewski | Oct 9, 2017
Melissa P. Wasserstein, MD, Chief of Pediatric Genetic Medicine at the Children’s Hospital at Montefiore, New York City discusses Niemann–Pick diseases, a subgroup of lipid storage disorders called sphingolipidoses in which harmful quantities of fatty...
by Peter Ciszewski | Oct 6, 2017
Emmy-Award Winning Actress Finola Hughes discusses why she is raising awareness for a group of rare, chronic and under-recognized blood cancers called Myeloproliferative Neoplasms (MPNs) Finola Hughes is dedicated to increasing awareness for rare blood cancers, while...
by Peter Ciszewski | Sep 29, 2017
Robert Derham, Founder of CheckOrphan discusses the Orphan Drug Act and some of the misconceptions surrounding it. Robert also talks about rare disease drug pricing. CheckOrphan: The Longest Running Website Focused Exclusively on Rare Diseases.
by Peter Ciszewski | Sep 28, 2017
Ellen Ritchie, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College, discusses the challenges of diagnosing Myeloproliferative Neoplasms (MPNs). MPNs are rare, chronic blood cancers. Chronic conditions last for a long period of time and may...